LongCut logo

Ozempic and the Brain: What GLP-1 Drugs Are Really Doing to Your Mind

By Dr. Leaf Show: Neuroscience & Mental Health

Summary

Topics Covered

  • GLP1s Rewire Brain Reward Circuits
  • Reward Dampening Flattens All Pleasures
  • Weight Rebounds Due to Biological Reset
  • Chemistry Outsourcers Willpower Identity
  • GLP1s Quiet Addiction Via Dopamine

Full Transcript

Imagine waking up and realizing you're simply not hungry. Not I already ate not hungry but gone. The signal itself muted. That's what millions of people

muted. That's what millions of people are describing on drugs like ompic wiggoi zepbound. Medications from a

wiggoi zepbound. Medications from a powerful class called GLP1 receptor agonists. They were designed for

agonists. They were designed for diabetes and have changed how we think about weight loss, metabolism, even longevity.

But here's what most people don't realize. GLP1s don't just slow your

realize. GLP1s don't just slow your stomach or lower your blood sugar. They

send messages from your gut to your brain directly into the circuits that shape appetite reward and motivation.

They calm the dopamine pool that normally drives us towards food. In

brain imaging studies, people on these drugs show reduced activation in regions tied to food reward. That's one reason the results are so dramatic. Less

craving, less snacking, less impulse.

But it's also why some patients say something unexpected.

Food just stopped being interesting. For

some, that is a relief. Finally, quiet

inside. But for others, it's a kind of numbness. Because when your brain learns

numbness. Because when your brain learns to turn down desire in one area, it doesn't always stop there. Some early

reports suggest that the same mechanism reducing food cravings also flatten pleasure. Not just for food, but for

pleasure. Not just for food, but for other forms of joy. People have reported mood dips or even depression while taking GLP1s. Regulators like the FDA

taking GLP1s. Regulators like the FDA and EMA haven't found a proven causal link, but they are watching closely. The

data so far mixed. Some individuals

report better mood from weight loss and better health markers. Others say they feel blunted like their internal reward volume has been turned down. And then

there's what happens when you stop. In

clinical trials, nearly 2/3 of the weight loss during treatment came back within a year after discontinuation.

Appetite returns often stronger. That's

not willpower, it's biology. Your body's

trying to reclaim balance after an artificial signal has been actually removed. But there is another side that

removed. But there is another side that really gets airtime. Researchers are

exploring how GLP1s may reduce addiction behaviors. Early data suggests that

behaviors. Early data suggests that these same neural changes could help quiet the urges for alcohol, nicotine, and even compulsive gambling. If that's

confirmed, these drugs might reshape more than [music] metabolism. They could

redefine how medicine treats compulsion itself. So, is this the miracle we've

itself. So, is this the miracle we've all been waiting for, or a new chapter in [music] how we outsource self-regulation to chemistry? If you're

on a GLP1 right [music] now, do you know what's happening in your brain, not just your body? And if [music] you are

your body? And if [music] you are considering it, do you understand the full implications, both the benefits [music] and the risks? In this week's

episode, I will unpack the neuroscience, the emerging research, and the [music] human stories behind these medications so you can make sense of what it really means when hunger and maybe even [music]

desire itself goes quiet.

Millions are [music] taking GLP-1 drugs to help manage appetite and weight, but few are realizing these medications may also be reshaping how the brain

experiences reward itself. That's the

part of the story that gets missed and it's where things can get really interesting. If you are on a GLP-1

interesting. If you are on a GLP-1 medication like a Zmpic, WGO, Mona or Zeppbound, you have probably noticed something more than smaller portions or fewer cravings. The change doesn't stop

fewer cravings. The change doesn't stop in your stomach. it reaches your brain.

Let's talk about what's really happening underneath the surface. P1 stands for glucagon like peptide 1. It is a hormone that your body naturally releases after

you eat. Under normal conditions, that

you eat. Under normal conditions, that signal lasts minutes. It slows the emptying of your stomach, stimulates insulin, and suppresses glucagon so blood sugar stays stable. It also tells

your brain you've had enough. GLP1

receptor agonists mimic that same hormone, but they stay active for days.

So instead of your appetite signal fading after lunch, it stays steady all week. You don't just feel full, you

week. You don't just feel full, you think about food differently because your brain is being told over and over that you have had enough. So what's

really going on in the brain when that happens? Those receptors aren't only in

happens? Those receptors aren't only in your gut. They are in your brain stem,

your gut. They are in your brain stem, your hypothalamus, and even your reward circuits in your brain. The vagus nerve carries messages from the gut up to an area called the nucleus tactus

solitarius or NTS in the brain stem.

That's the first relay station for appetite signals. From there, those

appetite signals. From there, those messages reach the hypothalamus, the part of your brain that manages energy balance and decides when to start or stop eating. GLP-1 activity here quiets

stop eating. GLP-1 activity here quiets neurons that drive hunger and activates neurons that promote fullness. That's

why you can walk past food that used to call your name and feel nothing. Here's

the upside. And here's the hidden layer most people don't know about. GLP1

receptors also sit inside the misolyic dopamine system, the network that handles motivation and reward. Think of

it as the brain's internal feedback loop for pleasure. When we anticipate

for pleasure. When we anticipate something we enjoy, dopamine neurons in an area called the vententral tegmental area fire, projecting to the nucleus ccumbent, creating a want signal. Food

used to trigger that surge automatically. GLP-1 drugs reduce the

automatically. GLP-1 drugs reduce the intensity of that firing, so the brain's reward response to high calorie food cues drops. That's not imagination.

cues drops. That's not imagination.

Imaging studies show reduced activation in these reward regions when people on simaglutide look at pictures of tempting foods. And that same mechanism might

foods. And that same mechanism might explain why some people report broader changes, less interest in drinking, smoking, or even scrolling. Early

research suggests that GLP-1 drugs can lower alcohol and nicotine consumption, likely by dampening those same dopamine circuits. It is why some scientists are

circuits. It is why some scientists are testing them for addiction treatment.

But the same process that lowers cravings can also flatten other types of pleasure. Dopamine doesn't distinguish

pleasure. Dopamine doesn't distinguish between food, laughter, or creativity.

When it quiets globally, life can feel a little muted. Dopamine also does not act

little muted. Dopamine also does not act in isolation. It acts within a complex

in isolation. It acts within a complex biochemical and neurological network.

That's where the emotional experience splits. Some describe freedom. Others

splits. Some describe freedom. Others

describe silence. One person says, "I'm feeling in control." Another says, "I miss caring about things." Neither is wrong. They are both describing the same

wrong. They are both describing the same system. The brain's reward network

system. The brain's reward network reacting differently based on its baseline wiring and chemistry. If these

drugs change how we eat, do they also change how we connect? Food is a cultural connector. We celebrate with

cultural connector. We celebrate with it, comfort with it, build relationships around it. When appetite fades, those

around it. When appetite fades, those moments shift. Someone might skip a

moments shift. Someone might skip a birthday dinner or feel detached at a family meal. It's not depression. It's

family meal. It's not depression. It's

biology playing out in real time. And

for many, that tradeoff feels worth it because of the health gains, weight loss, better blood sugar, reduced heart risk. But for others, it raises new

risk. But for others, it raises new questions about what satisfaction really means when it's pharmacologically managed. And when treatment pauses or

managed. And when treatment pauses or stops, the body remembers what it used to do. Appetite returns quickly,

to do. Appetite returns quickly, sometimes more forcefully. In follow-up

trials, most participants regained much of the lost weight within a year after discontinuing. That rebound isn't

discontinuing. That rebound isn't failure. It is physiology reestablishing

failure. It is physiology reestablishing balance. The brain's appetite circuits

balance. The brain's appetite circuits wake back up and dopamine sensitivity rebounds. For some, that means relief,

rebounds. For some, that means relief, the return of taste, joy, and energy.

But for others, it means old patterns and cravings resurface fast. We have

learned what these drugs do to appetite.

But the real question is what are they teaching your brain about desire itself?

And that's where the story gets more complex. GLP1 drugs work because they

complex. GLP1 drugs work because they alter the communication lines between gut and brain. They teach the body to interpret hunger differently and shift

how the brain calculates reward. The

science is remarkable and the effects are complex. This isn't about good or

are complex. This isn't about good or bad. It's about understanding that

bad. It's about understanding that appetite, motivation, and emotion share the same circuitry. Change one and you inevitably touch the others. If you are

on one of these medications, awareness is your best tool. Notice how your focus, mood, and social energy evolve alongside your appetite. That

observation doesn't replace medical advice. It simply helps you see the full

advice. It simply helps you see the full picture of what is happening inside your brain and body. Next, we'll zoom in on the brain itself, the hypothalamus,

the brain stem, and the dopamine circuits, and unpack GLP1 signaling reshapes the brain's language of hunger and pleasure. Every thought you have

and pleasure. Every thought you have about food starts deep in the mind, long before you taste a bite. And when you use a GLP1 drug, you're not just turning

down hunger, you're adjusting the hardware that is involved in motivation itself. That is the real story. And it's

itself. That is the real story. And it's

happening inside the circuits that shape reward, craving, and pleasure. So, let's

map this thing out clearly. Where does

this begin? In the gut. After you eat, specialized intestinal cells release GLP1. That hormone takes two routes

GLP1. That hormone takes two routes through the bloodstream and through the vagus nerve, a direct communication line to your brain stem. The first stop is in

the nucleus tactus solar or NTS, the brain's intake switchboard. It

translates those chemical messages into neural signals. From there, the

neural signals. From there, the information moves to the hypothalamus, the command center for appetite metabolism, and energy use. Inside the

hypothalamus, two opposing teams of neurons keep appetite balanced. One set

drives hunger, the other promotes fullness. GLP-1 activates the fullness

fullness. GLP-1 activates the fullness team and quiets the hunger team. That's

biology, not willpower. And it is the main reason these drugs work so well.

But here's the twist. Those receptors

don't stop at the hypothalamus. They

also appear inside your brain's reward circuit, the vententral tegmental area, and the nucleus encumbent. These regions

generate the want signal. When we

anticipate something pleasurable, dopamine neurons fire, pushing us towards that reward. GLP-1 drugs reduce that firing rate and imaging studies show lower activation in these reward

areas when people on semiglutide look at high calorie foods, pictures of it. That

means that food loses some of its pull and the brain's predictive coding recalibrates downward. Here's the

recalibrates downward. Here's the question that keeps researchers up at night. If these reward neurons quiet

night. If these reward neurons quiet down for food, what else might they quiet down for? And that's where the conversation turns from the hunger to

human behavior. Think about how many of

human behavior. Think about how many of our habits revolve around small dopamine hits, a snack, a scroll, a drink. Early

research suggests that GLP-1 drugs also lower alcohol and nicotine use. Same

mechanism, same circuit. The switch that dampens food craving can quiet other urges too. But there is a tradeoff.

urges too. But there is a tradeoff.

Dopamine doesn't label its targets. It's

the same chemical for food, joy, creativity, and drive. So when it quiets globally, some people feel calm. Others

feel muted. That doesn't mean the brain is broken. It means that the reward dial

is broken. It means that the reward dial has been turned, not removed. And how

that feels depends on where your baseline was to begin with. Now, let's

talk about what this looks like outside a lab. When your brain stops lighting up

a lab. When your brain stops lighting up for food, meals change, but so does meaning. Food is one of our social

meaning. Food is one of our social languages. We celebrate with it. We

languages. We celebrate with it. We

comfort with it. We connect with it. If

appetite fades, those shared rituals shift. A birthday dinner might feel

shift. A birthday dinner might feel quieter. A favorite recipe might lose

quieter. A favorite recipe might lose its thrill. It's not sadness. It's

its thrill. It's not sadness. It's

biology playing out in real time. And

for many, the benefits outweigh the change. For others, it raises a new

change. For others, it raises a new question. What does satisfaction mean

question. What does satisfaction mean when desire itself is managed chemically? And here's what most people

chemically? And here's what most people don't realize when they stop. Once the

drug clears, the hypothalamus and reward systems reset. Appetite hormones like

systems reset. Appetite hormones like ghland rise again and dopamine sensitivity rebounds. And that's why

sensitivity rebounds. And that's why hunger and weight often return within months. It's not failure, it's the brain

months. It's not failure, it's the brain restoring its old rhythm. For some, that rebound brings relief. food tastes alive again. For others, it's frustrating

again. For others, it's frustrating because the quiet is gone. Understanding

these circuits reframes the conversation. GLP-1 drugs don't just

conversation. GLP-1 drugs don't just affect calories or willpower. They

intervene in how the conscious mind brain connection loop related to eating interprets motivation itself. And for

many, that's transformative. For others,

it's destabilizing.

Both experiences are valid and both prove how connected appetite and the conscious mind really are. So here's the question worth staying with. When

medicine can mute the brain's drive for pleasure, what does that mean for who we become? That's not fear. That is

become? That's not fear. That is

awareness. In the next chapter, we will tackle the myths, the oversimplifications, the misunderstandings, and the viral claims that distort what GLP1 drugs

actually do. Because before we can

actually do. Because before we can debate them, we need to separate the science from the story. Should you be afraid of these drugs or just more informed about them? Because here is the

truth. GLP-1 medications like ampic wobi

truth. GLP-1 medications like ampic wobi mjano zip bound are changing lives but they also come with real side effects

real unknowns and a few myths that deserve to be retired.

Let's start with the biggest misconception that these drugs are simply hunger killers. That's not what's happening.

killers. That's not what's happening.

They are hormone modulators acting on both the gut and the brain. They do not erase hunger. They change how hunger

erase hunger. They change how hunger feels. That distinction matters because

feels. That distinction matters because it's also why the side effects can reach beyond appetite. Now, myth number two,

beyond appetite. Now, myth number two, these medications are a quick fix. No,

they are long-term metabolic tools. In

most clinical trials, once patients stop, where it gradually returns because hormonal signaling normalizes. That

rebound is biology, not failure. But it

also means if you start, you need a long-term plan with a clinician. This

isn't a 12week detox. It is a metabolic partnership.

And myth number three, they are just for vanity. In reality, these drugs were

vanity. In reality, these drugs were created for diabetes and have proven heart, kidney, and metabolic health benefits. But that doesn't mean they are

benefits. But that doesn't mean they are for everyone. The conversation needs

for everyone. The conversation needs nuance, not hype. Let's talk about the physical side effects. The ones you might have seen online but not explained

in context. Nausea, vomiting, and

in context. Nausea, vomiting, and constipation are the most common. They

happen because food stays in the stomach longer. When gastric emptying slows,

longer. When gastric emptying slows, your stomach stretch receptors keep sending the I'm full messages to the brain. That same mechanism can make

brain. That same mechanism can make meals uncomfortable early on. For most

people, these effects improve with dose adjustment and time, but for about one in five users, they can be moderate to severe. There is also a risk of

severe. There is also a risk of gallbladder inflammation, especially during rapid weight loss. Pancreatitis

has been reported, though it's rare.

Muscle loss can also occur if weight loss happens too quickly or if protein intake is too low. One 2024 analysis suggested lean mass can account for up

to 15% of total weight loss without resistance training. None of this means

resistance training. None of this means the drugs are unsafe. It means they are powerful and must be monitored carefully.

And then there is nutrition. Because

these medications blunt hunger, some people undereat. And when that happens,

people undereat. And when that happens, you can end up deficient in protein, B vitamins, or electrolytes, which can cause fatigue, dizziness, or brain fog.

The goal isn't starvation. It is

metabolic balance. If you are on a GLP1, you should be working with a dietician or clinician to protect muscle and micronutrient levels. Some patients

micronutrient levels. Some patients describe the early months as freeing.

They can walk past food without thinking. Others describe it as strange.

thinking. Others describe it as strange.

Meals feel optional, almost irrelevant.

They can be emotionally destabilizing if your identity or social life was tied to eating. Now, let's talk about the brain

eating. Now, let's talk about the brain and emotional side effects, the ones that don't show up on a pull label. Some

users report feeling emotionally flat or detached. Others feel calmer and more in

detached. Others feel calmer and more in control. The current research shows no

control. The current research shows no confirmed causal link between GLP-1 drugs and depression, but pharmacco vigilance data include reports of apathy

and low mood. The likely reason is dopamine tone. When your reward system

dopamine tone. When your reward system quiets globally, the brain's motivation circuits may fire less often. You might

still want to do things, you just don't feel the same spark. That doesn't mean your mental health is failing. It is

chemistry doing its job too well.

Document it. talk about it. Don't ignore

it. Mind management becomes crucial when this is happening. Which is one of the reasons I'm doing this particular podcast because when you understand what is happening in your body and your

conscious mind, you are more likely to understand where the depressed signals are coming from. This knowledge will help you manage these feelings because you won't be blindsided. I have had

people say, "I feel peaceful, but I also feel less me." Others describe a sense of emotional neutrality, less anxiety, but also less joy. These differences

depend on the baseline brain chemistry and stress levels of the person. So,

it's not uniform. It is individualized neurobiology. So, let's be transparent

neurobiology. So, let's be transparent about what we don't know yet about these GLP1s.

We don't have decades of data on how chronic, which means ongoing, GLP1 signaling affects the brain's reward system. We know dopamine activity

system. We know dopamine activity decreases during treatment, but we don't know whether it fully rebounds or partially recalibrates.

We also don't yet understand how these drugs affect reproductive hormones like LH and FSH longterm, especially in younger users. Some animal studies

younger users. Some animal studies suggest subtle changes, but human research is still ongoing. And then

there's cognition. Early research shows that GLP1s might improve blood flow and reduce inflammation in the brain, which could protect against Alzheimer's disease. But other scientists are asking

disease. But other scientists are asking whether long-term dopamine suppression might affect creativity, curiosity, or drive. The data simply isn't in yet. The

drive. The data simply isn't in yet. The

bottom line, these are potent neuroindocrine modulators, not benign supplements. Respect the power and

supplements. Respect the power and respect the unknowns. Here is what is equally fascinating. GLP1s may help

equally fascinating. GLP1s may help people break cycles of addiction.

There's some early studies that show reduced alcohol and nicotine intake and animal models suggest potential for opioids and stimulants. The same

circuitry that blunts food reward may also lower the drive for other substances.

This could represent a breakthrough in treating compulsive behaviors. But we

are still at the discovery stage.

Scientists caution that reducing desire across all domains could have psychological consequences from reduced compulsion to reduced curiosity. And if

that sounds complex, it is because desire is very complex. You can't

separate it clearly into good and bad.

It is the same circuitry for discipline, joy, and motivation because the brain does not think or distinguish. It simply

is the messenger of the mind. So should

you be taking a GLP1?

That depends on your health, your history, and your goals. These

medications are extraordinary when used responsibly under medical supervision and with good mind management. They

lower blood sugar. They protect the heart and dramatically reduce obesity related diseases. But they are not

related diseases. But they are not personality shapers or lifestyle substitutes. They work best when paired

substitutes. They work best when paired with mind management, nutrition support, adequate protein, resistance training, and a clear exit strategy if discontinued.

If you ever stop, expect appetite and cravings to return. Not because you've failed, but because your brain and gut resume normal communic. When the quiet

ends, it can feel like losing control.

But it is really your biology rebalancing.

The key is to plan. Gradually adjusting

food routines, reintroducing movement, and staying aware of how your mood shifts as dopamine tone normalizes.

Every medication that changes the brain's chemistry and neural structure changes daily life as well because there is a feedback loop between the mind, brain, and body. For some, that's

liberation. For others, it's

liberation. For others, it's negotiation. The goal isn't to fear

negotiation. The goal isn't to fear these drugs. that is to respect what

these drugs. that is to respect what they touch. GLP1s are one of the most

they touch. GLP1s are one of the most promising classes of drugs in modern medicine, but they are also one of the least understood. They can save lives,

least understood. They can save lives, but they can also change the texture of daily life. Considering the historical

daily life. Considering the historical pattern of exciting medical breakthroughs such as psychiatric drugs, for example, initially held as solutions to major challenges, but eventually

proving otherwise. It is really prudent

proving otherwise. It is really prudent that we exercise caution until more comprehensive data becomes available.

The next question isn't just medical, it's philosophical. When we outsource

it's philosophical. When we outsource self-control to chemistry, what happens to our sense of self? That's where we are headed next. We used to call it

discipline. Now we call it dosage. That

discipline. Now we call it dosage. That

is not a criticism. Let's be honest.

It's fascinating to watch medicine change behavior in real time. GLP1 drugs

didn't just change bodies, they changed the psychology of control itself. Here

is what's new beneath the surface. When

chemistry changes appetite, the brain's predictive coding system, the mechanism that decides what counts as reward, has to adjust. It is not just that food

to adjust. It is not just that food feels less exciting. The brain is literally updating its expectations about pleasure and effort. That's a

subtle but fundamental shift in how motivation gets organized on a physiological level. So for decades,

physiological level. So for decades, we've treated willpower as a moral metric. If you could resist temptation,

metric. If you could resist temptation, you were disciplined. If you couldn't, you were weak. These drugs have upended that equation. For the first time in

that equation. For the first time in history, chemistry can deliver what motivation couldn't. quieting hunger,

motivation couldn't. quieting hunger, curbing compulsion, and giving people the results that used to require constant self-management.

It's a scientific breakthrough, but it also forces us to rethink what self-control even means. If a medication can do what your mind once did, where

does that leave the concept of willpower? Is it obsolete or has it just

willpower? Is it obsolete or has it just evolved?

Control means something different now.

Here's the paradox. We praise efficiency in every part of our lives. Automation,

optimization shortcuts time management. But when we outsource

management. But when we outsource discipline to chemistry, it feels different somehow because willpower has always been tied to identity to moral

worth. GLP1s blur that line. They move

worth. GLP1s blur that line. They move

discipline from the realm of character into the realm of chemistry. The same

way that eyeglasses changed vision, these drugs are changing appetite. But

vision correction never carried moral weight. Appetite does and that is why

weight. Appetite does and that is why some people feel conflicted. The results

look like success but the mechanism feels like surrender. They have achieved control but not through effort. For some

that feels like relief. For others it feels like losing credit for their own success. And that raises a deeper

success. And that raises a deeper question. Does control still count if it

question. Does control still count if it comes from outside of you? When hunger

disappears, life can get quieter.

Sometimes too quiet. And for some that's peace. For others it feels a little

peace. For others it feels a little empty. When desire fades, so does the

empty. When desire fades, so does the emotional friction that drives growth.

You are not negotiating with yourself anymore. You are just neutral. You can

anymore. You are just neutral. You can

feel that shift even if you can't name it. And in that stillness, some people

it. And in that stillness, some people start to feel less alive.

Neuroscientists describe this as reduced neural variability. When reward circuits

neural variability. When reward circuits become less active, the brain's natural rhythm flattens. That can translate into

rhythm flattens. That can translate into a psychological quiet that feels peaceful for some and hollow for others.

It is an unexpected consequence of perfect control. The loss of tension

perfect control. The loss of tension that made life dynamic. We don't just crave food. We crave the spark of

crave food. We crave the spark of wanting. It's what drives us to create,

wanting. It's what drives us to create, to connect, to move. So when chemistry turns that spark down too far, you can start to feel detached from your own momentum. Humans don't like the

momentum. Humans don't like the emotional voids. When one desire

emotional voids. When one desire disappears, when one desire disappears, we often replace it with another. And

that's why some users find themselves channeling that lost energy elsewhere into work, into control, into anxiety.

The brain's reward system doesn't disappear. It adapts. And not always in

disappear. It adapts. And not always in the right direction. Here's where it gets really interesting.

The brain doesn't waste energy because it has limited energy. Neuroscientists

call this neuroplastic compensation.

When one motivational circuit quiets, others strengthen to maintain equilibrium.

If we are not careful, the search for balance can become a new compulsion.

Chasing productivity instead of food, obsession instead of satisfaction.

That's the hidden cost of pharmacological control. When you

pharmacological control. When you suppress one drive, others compete for its place. We are living in a moment

its place. We are living in a moment where control is currency. We take our steps, our macros, our heart rate, our

mood. We've gified discipline.

mood. We've gified discipline.

GLP-1 drugs are the logical next step, the biological extension of that obsession with optimization.

It is strange when you think about it.

We have optimized everything but how we feel. But when everything is measured

feel. But when everything is measured and medicated, where does intuition, that deep gift of insight from the non-concious mind go?

At what point do we stop listening to the body and start micromanaging it into silence?

Long-term chemical control also changes the body's stress loops in the hypothalamic pituitary axis.

Endocrinologists have observed that chronic appetite suppression can alter veagal tone and cortisol rhythms. These are the systems that regulate calm and

energy. It is another reminder that

energy. It is another reminder that biology is designed to seek balance even under pharmacological control. This

isn't anti-science. It's pro control without consciousness is just another form of dependence. Maybe it's time to redefine willpower altogether.

discipline in the age of chemistry isn't about resisting biology. It's about

understanding it. If you choose to use a GLP-1 drug with awareness, honesty, and medical supervision, that's still self- agency. The problem isn't in the

agency. The problem isn't in the molecule, it's in the mindset. When

people use these medications without awareness and self-regulation, that's when control becomes dependency.

And I get why people feel conflicted.

It's new territory. So the challenge isn't to reject help. It's to remain conscious while accepting it. The real

story of GLP1s isn't about vanity or shortcuts. It's about humanity's

shortcuts. It's about humanity's relationship with control. We built

technology to manage our emotions. And

now we built medicine to manage our impulses. Let's pause there because this

impulses. Let's pause there because this is where science and philosophy start to meet. At the neurological level, it's

meet. At the neurological level, it's all one non-thinking purely responsive network that does not distinguish between good and bad. Hunger, addiction,

motivation, different expressions of a single adaptive system. The question

isn't whether that's good or bad. It's

whether we still feel like ourselves when everything that used to challenge us becomes easy. Because when comfort comes without struggle, identity shifts.

That's not fear. It's awareness. And as

science keeps advancing, the next chapter takes us even deeper into the circuitry of craving itself. If hunger

and addiction share a pathway, what else might we be rewiring? Next, we'll

explore where this evolution might lead into something scientists are only beginning to understand. The overlap

between hunger, addiction, and desire itself. Here's what's surprising. Hunger

itself. Here's what's surprising. Hunger

and addiction share the same circuitry.

The same signals, the same chemistry, just different labels. Change one and you change both. When a drug changes how the circuit fires, it doesn't just

change what you eat. It changes how you learn to want. If this is not managed, the conscious mind falls under a spell that quite literally blocks its access

to insightful curiosity and logical reasoning and creative solutions for your life. Here's where the science gets

your life. Here's where the science gets fascinating. The same neural pathways

fascinating. The same neural pathways that make you reach for food are the ones that make someone reach for a cigarette, a drink, or even a phone.

There is no distinction because the brain doesn't think, the mind does the thinking. It is the misolyic dopamine

thinking. It is the misolyic dopamine pathway, a line that runs from the vententral tegmental area in the brain to the nucleus circumbent. both of these deep down in the brain. These are the

brain's motivational little engine designed to activate as we translate desire into action. GLP1 receptors live right there. And when they are

right there. And when they are activated, they change how those neurons talk to each other or communicate with each other. Neurons act as antenna,

each other. Neurons act as antenna, constantly receiving information signals that shapes our human experience. The

interplay between GLP-1 signals in the media and the body's actual GLP-1 signals appears to be generating a range of signals. These collectively seem to

of signals. These collectively seem to exert a dampening influence on the mind and the brain. So instead of getting a surge of dopamine in response to cues

like sugar, alcohol, scrolling, the signal softens. You don't just eat less,

signal softens. You don't just eat less, you feel less pull.

This is why scientists are so interested. If you can turn down the

interested. If you can turn down the intensity of craving in one domain, maybe you can reduce it in others. Early

evidence says that might be true. In

early human trials, people on simaglutide report drinking less alcohol without even trying. Others found they were smoking less or that the reward of

those habits just wasn't there anymore.

Animal studies go further. GLP1

signaling seems to reduce self- administration of cocaine, nicotine, and opioids. It's all the same biology.

opioids. It's all the same biology.

Lower dopamine, burst amplitude, less incentive silence, less compulsive drive. That sounds incredible. Dopamine

drive. That sounds incredible. Dopamine

isn't selective, though. When you turn that system down, you don't just quiet cravings. You also quiet the energy that

cravings. You also quiet the energy that pushes you towards doing things. So,

there's a price to pay. For some people, that feels calm, finally free of the pool. For others, it feels muted, like

pool. For others, it feels muted, like the color turned down in daily life. So

it's not depression. It's the brain running on a lower dopamine tone, a steadier state that can feel peaceful or flat depending on who you are, what you do in the context of your life. If you

understand this, it helps to manage the feelings of flatness as being a reaction to the nonspe to the nonspecificity of GLP1's effects.

Imagine a medicine that can silence addiction, but also dull excitement.

What happens to a world where nothing feels urgent anymore? That's the paradox of GLP1s.

They are stabilizers of motivation. They

flatten the peaks of craving, but also the highs of satisfaction. In

neurosciences is called hedonic tone, the brain's baseline for pleasure. Gopia

ones seem to raise the floor so that there's fewer lows, fewer compulsions, but they also may lower the ceiling.

It's like trading a roller coaster for a monor rail. Smoother, safer, but slower.

monor rail. Smoother, safer, but slower.

For some people, that's healing. For

others, it's a loss of spark. We don't

yet know what happens when you keep that system quiet for years. Does the brain recalibrate? Do dopamine neurons regain

recalibrate? Do dopamine neurons regain their old rhythm?

Or does the motivational baseline shift permanently?

Researchers studying the misoccordic system suspect long-term adaptation. The

brain is plastic. It learns. It gets

rewired by the mind. When one circuit goes quiet for too long, others compensate and networks reconstruct in different ways, driving different behaviors. That's called feedback

behaviors. That's called feedback reorganization.

New patterns forming to preserve balance. It is the brain's version of

balance. It is the brain's version of home renovation. But sometimes when you

home renovation. But sometimes when you move the walls, you change how the space feels. That's the unknown. Are we

feels. That's the unknown. Are we

improving impulse control or slowly training the brain to live with less reward? But let's just pause for a

reward? But let's just pause for a moment here. For people living in

moment here. For people living in addiction, that quiet is a miracle. For

someone who spent years chasing a drink, a hit, a binge, peace feels like freedom. And for the first time,

freedom. And for the first time, neuroscience might offer recovery not through restraint, but through relief.

Clinicians are already testing GLP1s as adjunct treatments for alcohol and nicotine dependence. The mechanism is

nicotine dependence. The mechanism is clear. By lowering the reward signal,

clear. By lowering the reward signal, the brain stops overvaluing the next fix. That's not moral triumph. It's

fix. That's not moral triumph. It's

biology helping the mind breathe again.

Still, this relief comes with trade-offs. Some users describe a

trade-offs. Some users describe a strange neutrality. Fewer highs, fewer

strange neutrality. Fewer highs, fewer lows. It's emotional equilibrium. And

lows. It's emotional equilibrium. And

while it saves some people, it can unsettle others. We are learning that

unsettle others. We are learning that you can heal the circuitry of craving, but you might also quiet the circuitry of passion. Addiction isn't just about

of passion. Addiction isn't just about substances.

It is about meaning. It is the mind and brain search for stimulation and relief.

for something to fill the space between discomfort and satisfaction. When a drug can regulate desire itself, it doesn't just change your behavior, changes who

you are when you are not chasing anything. Brain imaging studies show

anything. Brain imaging studies show something fascinating. When dopamine

something fascinating. When dopamine variability drops, the default mode network, which is the brain system that responds to introspection, becomes more

dominant. That could explain why some

dominant. That could explain why some GLP1 users report feeling detached or more reflective, less external seeking, more internal

observation. It's not just numbing, it's

observation. It's not just numbing, it's an inward redirection. Depending on your personality, that can feel grounding or maybe isolating. For some, it's

maybe isolating. For some, it's mindfulness, for others, it's monotony.

The data so far shows that when treatment ends, the system rebounds. As

I've mentioned a few times now, sometimes really sharply. Dopamine

sensitivity spikes. Appetite hormones

rise. Cravings return fast. That's the

body trying to reassert equilibrium.

Emotionally, it can feel like withdrawal. Not from the drug, but from

withdrawal. Not from the drug, but from calm. You start to feel urgency again

calm. You start to feel urgency again about food, about drive, about everything. That is the nervous system

everything. That is the nervous system coming back online. And if you're not prepared, it's disorientating because you've forgotten what constant wanting

actually feels like. So maybe the question isn't where the GLP1s make us less addicted.

Maybe they have simply given addiction a new name. Control. Next, we'll talk

new name. Control. Next, we'll talk about what happens when that control ends. When the quiet fades, the cravings

ends. When the quiet fades, the cravings return, and the mind has to learn hunger again. Everyone talks about starting

again. Everyone talks about starting these drugs. Hardly anyone talks about

these drugs. Hardly anyone talks about what happens when you stop. That's when

the real adjustment begins. The

medication fades. The body resumes normal regulation and signals that were muted begin to reappear.

Some people find that change empowering.

Others find it confusing. The important

point is that the body is reestablishing balance or attempting to reestablish balance. When GLP1 treatment ends,

balance. When GLP1 treatment ends, appetite related hormones shift very quickly. Grein, which stimulates hunger,

quickly. Grein, which stimulates hunger, increases. Leptin, which promotes

increases. Leptin, which promotes fullness, decreases. Food begins moving

fullness, decreases. Food begins moving through the stomach at its natural rate.

Again, hunger typically returns within days or weeks. These changes indicate that appetite regulation is resuming normal function. Many people notice that

normal function. Many people notice that meals feel more satisfying, but also more tempting. It can take a few weeks

more tempting. It can take a few weeks for hunger cues to stabilize as hormone levels adjust. This is a normal

levels adjust. This is a normal biological response. The brain also

biological response. The brain also adapts once the medication clears.

Dopamine activity in the reward system increases which restores sensitivity to normal cues. People often notice that

normal cues. People often notice that food smells stronger or that cravings appear more frequently. And these

reactions are part of the brain's effort to return to baseline responsiveness. So

scientists describe this phase as predictive recalibration. The brain is

predictive recalibration. The brain is matching expectations with actual experiences again, and cravings can temporally feel stronger before stabilizing, which reflects the nervous

systems process of readjusting reward prediction. Over time, these signals

prediction. Over time, these signals level out as consistency does return. As

brain chemistry and structure shifts, emotional states shift as well. Some

individuals report increased motivation or alertness while others experience temporary mood swings or restlessness.

See, the mind is also affected. These

reactions correspond with neurotransmitter systems returning to their typical range and networks. People

who experienced emotional calm during treatment can find this new variability unfamiliar. This is where knowledge

unfamiliar. This is where knowledge about this will help that fluctuation represents a normal translation as the body reestablishes its natural pattern of responsiveness. But you need to

of responsiveness. But you need to understand that and know how to manage that. Emotional rhythm stabilizes with

that. Emotional rhythm stabilizes with time and routine and mind management.

The body may send clear hunger signals before the brain actually remembers how to interpret them. So after GLP-1 therapy, it takes time to reconnect physical cues with appropriate eating

responses. And this process called

responses. And this process called homeostatic relearning involves coordination between the gut and the brain's reward and decision-m centers.

And it needs to be managed by your mind, you with your mind. Research shows

increased activity in the insula and orbital frontal cortex areas that respond when we evaluate internal sensations and satisfaction. And during

early stages, hunger can appear without clear preference or fullness can occur without a sense of satisfaction.

Communication between hormones and perception improves as this system resets. Social expectations can also

resets. Social expectations can also complicate this phase of relearning and rebalancing.

Weight loss achieved during treatment is often celebrated while the return of appetite is viewed negatively. So public

perception rarely matches biological reality. So those old networks get

reality. So those old networks get reactivated.

Appetite returning indicates that hormonal communication is working properly. Healthare providers recommend

properly. Healthare providers recommend focusing on nutrition, structured meals and ongoing medical guidance to maintain balance. Mind management however through

balance. Mind management however through this process is absolutely key. and it

involves support and education and all this reduces the guilt and misunderstanding during this adjustment period. In the months following

period. In the months following discontinuation, metabolism and appetite gradually stabilize. Some weight gain is

gradually stabilize. Some weight gain is common as resting metabolism increases and appetite regulation rebalances. As

I've mentioned a few times, this pattern reflects the body's effort to get that energy equilibrium going again. Many

people maintain better awareness of portion size or reduce compulsive eating after therapy. If you bring mind

after therapy. If you bring mind management into the picture, others return to prior habits over time without mind management. Results often depend on

mind management. Results often depend on behavioral routines, physical activity, and nutrition maintained during and after treatment. The medication alters

after treatment. The medication alters the biochemical signaling, while long-term outcomes depend on consistency and support. The reappearance of

and support. The reappearance of appetite signals that biological systems are functioning as expected. Hunger does

reflect normal hormonal and neural communication. So if you recognize this

communication. So if you recognize this change as part of recovery, it can help you interpret your expectations more accurately. This is pure mind

accurately. This is pure mind management. Understanding hunger as a

management. Understanding hunger as a feedback mechanism provides you with perspective. It allows individuals to

perspective. It allows individuals to respond with awareness and self-regulation rather than concern and worry. The process of appetite returning

worry. The process of appetite returning represents a healthy phase of adjustment following treatment. So in the next

following treatment. So in the next chapter, we'll examine hunger itself.

How it integrates biology, emotion, and motivation to shape human behavior.

Hunger has been treated as something to suppress or manage. But hunger isn't the problem. It is a biological signal that

problem. It is a biological signal that shows normal regulation between the body and the brain. When hunger appears, the body systems are operating as expected.

Understanding that process gives perspective on how motivation and energy connect. Hunger in this context is not

connect. Hunger in this context is not just about food. It's a sign of life awareness and balance. Hunger is not limited to the stomach. It involves

hormones, neurons, and feedback loops that include the hypothalamus, brain stem, and reward systems. When blood sugar drops, grein rises and stimulates appetite. The hypothalamus integrates

appetite. The hypothalamus integrates that data with other information from the body to determine where the energy intake is needed. These processes keep the individual alert to biological

requirements for survival. The brain

detects subtle drops in blood glucose and changes in attention or mood before the individual consciously recognizes them as hunger. This is why hunger can show up as distraction, irritability, or

fatigue long before the stomach actually growls. Hunger activates more than the

growls. Hunger activates more than the physical need for food. The same

dopamine-driven networks that encourage eating also support curiosity, focus, and motivation. Very important for your

and motivation. Very important for your human day-to-day living. When those

networks quiet, motivation and emotional drive and curiosity can decrease, and that's not good. The brain doesn't isolate physical need from emotional engagement. Your brain doesn't know how

engagement. Your brain doesn't know how to distinguish. It interprets or filters

to distinguish. It interprets or filters or reflects both through the same reward and learning systems. And modern environments complicate this relationship. Constant stimulation,

relationship. Constant stimulation, phones, work demands, caffeine, late nightlight can drown out the subtle appetite signals. The system still sends

appetite signals. The system still sends messages, but they are harder to interpret. And over time, that

interpret. And over time, that disconnection can resemble burnout, irritability, or impulsive eating. When

the brain loses clear feedback from hunger and satiety cues, conscious emotional regulation can weaken as well.

Cultural narratives have distorted how people interpret hunger. Public

messaging equates control with virtue and appetite with weakness. In

biological terms, a functioning appetite system signals health, not disorder.

Suppressing that signal for extended periods can affect mood, energy, and attention. Hunger is a measurable

attention. Hunger is a measurable feedback process, not a reflection of character. Entire industries profit from

character. Entire industries profit from the belief that control equals success.

diets, supplements, and productivity methods all rely on the same assumption that comfort and restraint prove discipline. But biology doesn't

discipline. But biology doesn't negotiate with trends because it is designed to respond to need. Every time

hunger is silenced instead of managed, this is key. Every time hunger is silenced instead of managed, other systems adapt to compensate. And that's

why chronic suppression often leads to fatigue, overeating, or emotional exhaustion. Later, hunger influences

exhaustion. Later, hunger influences emotional and physiological readiness.

When the body detects an energy deficit, stress hormones shift, and attention narrows to encourage action. Learning to

recognize and respond appropriately to these changes supports balance and emotional stability. When appetite cues

emotional stability. When appetite cues remain absent, emotional awareness and self-regulation can actually get less.

Appetite feedback contribute to regulation. Variation between hunger and

regulation. Variation between hunger and fullness maintains equilibrium.

Recognizing these signals helps maintain steady behavior and mood. Research in

psychopysiology shows that individuals who accurately identify hunger and fullness tend to have stronger impulse control and lower stress reactivity.

This isn't about dieting. It's about

introsception. The ability to read the body's internal state and be curious about it. This is reading the signals

about it. This is reading the signals from the non-concious mind that are moving through the body telling us something. Improved interceptive

something. Improved interceptive awareness correlates with better emotional resilience and decision making. Appetite, reward, addiction, and

making. Appetite, reward, addiction, and motivation all operate through the same interconnected network. The gut and

interconnected network. The gut and brain communicate continuously through hormonal and neural pathways. When

signaling decreases in one area, other systems compensate. This shared

systems compensate. This shared infrastructure explains why changes in appetite can influence focus, emotion or behavior. And the key is understanding

behavior. And the key is understanding the communication rather than judging it. In neuroscience, this interaction is

it. In neuroscience, this interaction is often referred to as the gutb brain axis. The same neurotransmitters

axis. The same neurotransmitters dopamine, serotonin, and GLP1 play roles in both appetite regulation and emotional balance. When one pathway

emotional balance. When one pathway changes, the rest reorganize to maintain homeostasis.

Recognizing this pattern turns what seems like a contradiction into coherence. Each hunger signal represents

coherence. Each hunger signal represents a form of need. Sometimes nutritional,

sometimes emotional, and sometimes cognitive.

Interpreting that signal correctly creates stability.

Responding accurately builds control.

Control improves through awareness and understanding, not through suppression of cues.

Awareness in this context isn't philosophical, very practical.

Knowing what a hunger signal means allows for better self-regulation.

Sometimes it calls for nourishment.

Sometimes it means rest or pause. When

people learn to respond precisely, energy and emotions stay more consistent throughout the day. This is mind management in action. So across this

series we have looked at appetite, control, reward and adaptation. All of

these systems function as part of one regulatory network. When communication

regulatory network. When communication between them weakens, regulation becomes inconsistent. Coordination improves.

inconsistent. Coordination improves.

Hunger indicates active communication amongst biological systems. Recognizing that connection clarifies the purpose of appetite and desire. And the objective

is not to eliminate those responses, but to interpret them accurately and maintain equilibrium.

Hunger in its most basic form keeps the feedback loop between the body and the mind intact. Understanding it removes

mind intact. Understanding it removes judgment and replaces it with information. When that understanding

information. When that understanding deepens, control becomes less about resistance and more about precision.

That's how awareness translates into long-term balance. In the next chapter,

long-term balance. In the next chapter, we will examine how awareness of these signals supports long-term health, self-regulation, and a balanced relationship with biology. We began this

series by asking what these medications do to the brain. Now, we can see what they reveal about it. Every system we explore from hunger, motivation, emotion, reward work as one continuous

conversation between the gut, brain, and the mind. The goal was never to just

the mind. The goal was never to just explain the drug.

It was to understand what happens when chemistry changes how we experience control, satisfaction, and need. Over

these chapters, we've seen how GLP1's alter hormonal signaling, reduce dopamine firing, and reshape the link between craving and reward. We've also

seen how that same circuitry regulates creativity, emotion, and drive. When

those systems quiet motivation changes, when they reactivate hunger and emotion return, everything's connected. mind,

brain, body. The biology of appetite is also the biology of purpose. That

connection is what makes the story bigger than weight loss. It's about what happens when the body's most ancient communication system is redesigned by

modern science. The main insight isn't

modern science. The main insight isn't about the medication. It's about

awareness and self-regulation.

Every adjustment, every craving, every emotional fluctuation is feedback.

awareness and self-regulation turns that feedback into information instead of judgment. When people understand how

judgment. When people understand how these systems work, they stop seeing hunger or desire as personal flaws. They

start seeing them as signals that can be managed, studied, and respected. Real

control doesn't come from silence. It

comes from understanding what the signal means and responding intentionally.

That's what neuroscience confirms. The brain isn't against you. It's built to adapt to the input it receives from you.

Learning to interpret that input accurately is the foundation of mental and emotional stability and the core of mind management. We do live in a time

mind management. We do live in a time that celebrates optimization and control as I have mentioned numerous times in this podcast. But the body doesn't speak

this podcast. But the body doesn't speak the language of perfection. It speaks

the language of balance.

We have built systems that reward suppression and speed while biology depends on rhythm and recovery. When

that rhythm is ignored, emotional regulation weakens and cognitive fatigue will set in. The more people understand their biology, the less they confuse normal fluctuation with failure. And

that's why education matters and education is part of mind management.

People deserve accurate, compassionate science about their brain and their bodies and their mind. When we remove the moral lens, what is left is curiosity. And that's where real change

curiosity. And that's where real change begins. The next stage in health isn't

begins. The next stage in health isn't about more control. It's about

partnership. We are moving towards an era where biology, behavior, and technology work together. Medication can

support that process, but understanding must lead it. Mind must lead it. No

prescription can replace the awareness that comes from observing your own patterns, reactions, and thoughts. This

kind of awareness builds stability that lasts long after the treatment ends.

It's not dramatic. It's the difference between managing symptoms and mastering understanding. So, what have we learned?

understanding. So, what have we learned?

That hunger isn't just physical. It's

cognitive. It's emotional and cultural.

It's one of the most direct ways your brain communicates need.

When you understand it, you stop trying to eliminate it. You learn from it. That

is the foundation of true awareness.

Awareness and self-regulation are medicine. It is what rewires the brain

medicine. It is what rewires the brain and changes behavior long term. Each new

year, we make resolutions, but most of them fade by week two. The truth is, it's not about willpower. It is about neuroplasticity.

Your mind has the power to direct your brain to calm anxiety, break mental habits, boost focus, and build new lasting patterns of peace and clarity.

And that is why I created the 21day New Year brain detox challenge. Inside the

reset program starting January 1st, every day you will go through my brand new reset course on your own schedule using my five-step neuroscycle method.

the same scientifically proven process I've used with millions worldwide to transform their minds and detox their brain. You'll also get access to private

brain. You'll also get access to private group forums for community support and Q&A, daily Instagram check-ins from me to keep you motivated and even

opportunities for one-on-one coaching sessions. If you have been feeling

sessions. If you have been feeling stuck, stressed, or simply ready to start the year with a clear mind and detox brain, this is your reset. The

first 100 people to join get $50 off. So

don't miss out. The link to join will be in the show descriptions below. Because

this year isn't about resolutions. It is

about rewiring your mind for lasting change. To stay connected with me,

change. To stay connected with me, subscribe to my weekly newsletter for new research updates and mental health tools at drleaf.com/newsletter

or visit my website drleaf.com for articles and podcasts or explore my app neuroscycle for daily guided exercises.

The conversation between the mind, the brain, and the body never stops. The

more you understand it, the better you live within it.

Loading...

Loading video analysis...